Tag: PRR

Prima BioMed PRR safety milestone breast cancer

Prima BioMed’s breast cancer drug achieves safety milestone

Prima BioMed (ASX: PRR; NASDAQ: PBMD) has announced positive safety and efficacy data from the safety run-in stage of its clinical trial for IMP321 (LAG-3Ig) in metastatic breast cancer (MBC) at the A...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS